C-J Advisory’s Hologic HOLX Stock Holding History

C-J Advisory’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-251	Closed	-$9K	–	169
2018 Q1	$9K	Hold	251	–	–	0.01%	115
2017 Q4	$11K	Hold	251	–	–	0.01%	110
2017 Q3	$9K	Hold	251	–	–	0.01%	114
2017 Q2	$11K	Hold	251	–	–	0.01%	101
2017 Q1	$11K	Hold	251	–	–	0.01%	102
2016 Q4	$10K	Hold	251	–	–	0.01%	102
2016 Q3	$10K	Buy	+251	New	+$9.47K	0.01%	102

Other funds holding HOLX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

C-J Advisory's HOLX Position: Q2 2018 in Review

C-J Advisory sold out of Hologic (HOLX) in Q2 2018, closing a stake of 251 shares — an estimated $9K sold.

C-J Advisory first reported a position in HOLX in Q3 2016 and held it in 7 quarters. The position peaked at $11K in Q4 2017. 449 funds tracked by Wall St. Rank hold HOLX as of Q2 2018.

C-J Advisory reported no remaining Hologic position as of Q2 2018 after selling out during the quarter.
C-J Advisory sold 251 Hologic shares in Q2 2018, an estimated $9K.
C-J Advisory first reported a position in Hologic in Q3 2016 and held it in 7 quarters.
C-J Advisory's Hologic position peaked at $11K in Q4 2017.
449 funds tracked by Wall St. Rank held Hologic as of Q2 2018.

Based on C-J Advisory's 13F filing for Q2 2018, filed 3 May 2019.